CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
西格列汀与瑞格列奈比较治疗2型糖尿病效果的系统评价
Authors
余亚信
胡鹏里
陈婧
Publication date
1 July 2018
Publisher
'Orthopterists'' Society'
Doi
Cite
Abstract
目的运用循证医学方法 ,对西格列汀与瑞格列奈治疗2型糖尿病的随机或者半随机对照试验进行系统评价。方法全面收集2018年3月以前发表的以西格列汀与瑞格列奈治疗2型糖尿病的随机或者半随机对照试验文献,逐一评价文献质量;运用RevMan4.2软件对多个研究结果的总体效应进行Meta分析。结果 8篇文献被纳入研究,只有3篇明确描述随机方法。Meta分析结果提示西格列汀组改善空腹血糖优于瑞格列奈组,且两组差异有统计学意义[WMD-0.19,95%CI(-0.28,-0.10),P<0.0001];西格列汀组改善餐后2 h血糖、糖化血红蛋白均优于瑞格列奈组,但两组差异均无统计学意义,分别为[WMD-0.05,95%CI(-0.24,0.15),P=0.64]和[WMD-0.02,95%CI(-0.11,0.07),P=0.68];西格列汀组降低BMI的幅度大于瑞格列奈组,且差异有统计学意义[WMD-1.44,95%CI(-1.73,-1.15),P<0.000 01]。结论目前资料表明,西格列汀组改善血糖情况非劣效于瑞格列奈组,且对体重影响更小、低血糖事件更少,但此次所纳入的研究总体质量等级不高,对结果的论证强度具有一定影响,建议今后进一步开展更多高质量的临床研究以提供更加可靠的证据
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Xiamen University Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dspace.xmu.edu.cn:2288/173...
Last time updated on 10/06/2020